Showing results (391-400 of 566) with videos related to

Sort By:
Pageof 57
Annals of the Rheumatic Diseases|July 10, 2012
Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensusSusan J Bartlett, Sarah Hewlett, Clifton O Bingham, et al.
The Journal of Rheumatology|May 3, 2015
Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014William Tillett, Lihi Eder, Niti Goel, et al.
Rheumatology Advances in Practice|November 15, 2021
Change in psoriatic arthritis outcome measures impacts SF-36 physical and mental component scores differently: an observational cohort studyMarie Skougaard, Tanja S Jørgensen, Mia J Jensen, et al.
The Journal of Rheumatology|March 4, 2014
How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0Maarten Boers, John R Kirwan, Laure Gossec, et al.
Seminars in Arthritis and Rheumatism|August 16, 2021
OMERACT Filter 2.1 instrument selection for physical function domain in psoriatic arthritis: Provisional endorsement for HAQ-DI and SF-36 PFYing-Ying Leung, Ana-Maria Orbai, Pil Hojgaard, et al.
Rheumatology and Therapy|August 21, 2020
Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 WeeksHelena Marzo-Ortega, Philip J Mease, Proton Rahman, et al.
The Journal of Rheumatology|August 3, 2015
Harmonizing Pain Outcome Measures: Results of the Pre-OMERACT Meeting on Partnerships for Consensus on Patient-important Pain Outcome Domains Between the Cochrane Musculoskeletal Group and OMERACTKristine Phillips, Ann Taylor, Philip J Mease, et al.
Seminars in Arthritis and Rheumatism|September 14, 2020
Clinical trial discrimination of physical function instruments for psoriatic arthritis: A systematic reviewYing-Ying Leung, Richard Holland, Ashish J Mathew, et al.
Rheumatology (Oxford, England)|July 9, 2025
Type I interferon limits interleukin-6 signaling in SLE through shedding interleukin-6 receptors]Martyna Hempel, Erik Klapproth, Annika Krause, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 5, 2014
Meta-analysis of assay sensitivity and study features in clinical trials of pharmacologic treatments for osteoarthritis painRobert H Dworkin, Dennis C Turk, Sarah Peirce-Sandner, et al.
Pageof 57